PRISMAP: A European network for medical radioisotope production and research

October 1, 2021, 12:00PMNuclear News
A conceptual image of collaboration across Europe. (Image: PRISMAP/SCIPROM)

Only a few of the more than 3,000 radioisotopes that scientists have synthesized in the laboratory are regularly used in diagnostic or therapeutic medicine. One significant barrier to the development of new medical radioisotopes is the difficulty of gaining access to radionuclides during the early stages of development and research. PRISMAP is a new medical radionuclide program designed to streamline that access for medical research in the European Union and the United Kingdom.

To continue reading, log in or create a free account!

Related Articles

2023 in Review: April–June

January 11, 2024, 7:00AMNuclear News

Another calendar year has passed. Before heading too far into 2024, let’s look back at what happened in 2023 in the nuclear community. In today's post, compiled from Nuclear News and Nuclear...